Salar A, Fernández de Sevilla A, Romagosa V, Domingo-Claros A, González-Barca E, Grañena A
Servicio de Hematología Clínica, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona.
Med Clin (Barc). 1999 Feb 27;112(7):255-6.
To analyze peripheral non-cutaneous T-cell lymphomas (NC-TCL) and to test the significance of the IPI.
Twenty-nine consecutive patients diagnosed with NC-TCL according to the REAL classification.
At diagnosis were common: B symptoms (21%), stage III/IV (55%), high LDH level (55%) and extranodal involvement (79%). Twelve (48%) patients achieved complete remission. The IPI identified groups of patients with different response to therapy and survival.
NC-TCL with high or high-intermediate IPI had a short survival if treated with CHOP.
分析外周非皮肤T细胞淋巴瘤(NC-TCL)并检验国际预后指数(IPI)的意义。
根据REAL分类法,连续纳入29例诊断为NC-TCL的患者。
诊断时常见情况如下:B症状(21%)、Ⅲ/Ⅳ期(55%)、乳酸脱氢酶(LDH)水平升高(55%)及结外受累(79%)。12例(48%)患者达到完全缓解。IPI可区分对治疗反应及生存情况不同的患者组。
CHOP方案治疗时,IPI为高危或高中危的NC-TCL患者生存期短。